Jeff Shuren said he was happy to speak at Medcon because he had “better news” than he had spoken of during the years of the COVID-19 pandemic.
Shuren Says CDRH Is ‘Turning The Ship Around’ As Operations Return To Normal
The director of the US FDA’s device center discussed several of the center’s priorities at Medcon, such as moving beyond the pandemic, focusing on patients, and advancing health equity.
